FLFangrui Lin

Fangrui Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fangrui Lin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Junle Qu

    Affiliation College of Physics and Optoelectronic Engineering, Center for Biomedical Photonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen, P. R. China

    2 shared publications
  • Junle Qu

    Shenzhen University

    2 shared publications
  • Andrii Golovynskyi

    Affiliation V.M. Glushkov Institute of Cybernetics, NAS of Ukraine, Kyiv, Ukraine

    1 shared publication
  • Binglin Shen

    Key Laboratory of Optoelectronic Devices and Systems of Guangdong Province and Ministry of Education, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, China

    1 shared publication
  • Binjun Li

    Affiliation College of Physics and Optoelectronic Engineering, Center for Biomedical Photonics, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen University, Shenzhen, P. R. China

    1 shared publication
  • Changrui Liao

    Shenzhen University

    1 shared publication

Latest Publications

  • Open Access

    Transcranial photobiomodulation therapy with 808 nm light changes expression of genes and proteins associated with neuroprotection, neuroinflammation, oxidative stress, and Alzheimer’s disease: Whole RNA sequencing of mouse cortex and hippocampus

    by Binjun Li, Iuliia Golovynska, Yurii V. Stepanov, Sergii Golovynskyi, Andrii Golovynskyi, Denis Kolesnik, Liudmyla I. Stepanova, Puxiang Lai, Fangrui Lin, Junle Qu

    Light therapy, using red and near-infrared (NIR) irradiation, is currently applied for the treatment of various neurodegenerative diseases, such as Alzheimer’s disease (AD). Transcranial photobiomodulation therapy (tPBMT) can alleviate neurodegeneration, neuronal loss, and β-amyloid peptide plaque burden. Alternatively, potential early inhibition of oxidative stress, neuroinflammation, apoptosis, and amyloidogenic cellular pathways may constrain pathological changes with aging. In this research, we conduct an 808-nm tPBMT with a 30-day course of daily 1-hour sessions for mice and assess its influence on molecular mechanisms related to the potential onset of neurodegeneration. To comprehensively identify molecular mechanisms of tPBMT on the brain cells, the next-generation whole RNA sequencing of over 30,000 mRNA of the cortex and hippocampus of BALB/c mice is performed. After tPBMT, transcriptional alterations are found in 1,005 genes in the hippocampus and 1,482 genes in the cortex. Pathway-gene enrichment network analysis identifies genes associated with about 20 pathways of neurodegeneration, and a disease-gene network is constructed. Particularly, tPBMT alters the transcription and expression of the essential genes associated with oxidative stress (NF-κBIα, JUN, JUND, and PKC genes), inflammation (DOCK4/6, IL-1RAPL1, and TNFαIP6), and apoptosis (CASP3, TNFαIP6, AKT3, CDKN1A, CYP51, RASA2, and RESTAT). Additionally, 808-nm light modulates the main risk genes for AD (BACE1, BACE2, PSEN2, APH1B, GATA2, YY2, RELA, STAT3, JUN, JUND, ARNTL, CREB3L1, CELF2, E2F4, ELK3, and CEBPD), involved in APP processing supporting AD development. Moreover, the APP concentration is reduced after tPBMT. Hence, PBMT may help inhibit the development of different neurodegeneration types and maintain normal brain conditions.


  • Biopharmaceutical drug delivery and phototherapy using protein crystals

    by Renbin Zhou, Jinghan Qu, Xuejiao Liu, Fangrui Lin, Tymish Y. Ohulchanskyy, Nuernisha Alifu, Junle Qu, Da-Chuan Yin


  • Open Access

    Enhancing Therapeutic Response and Overcoming Resistance to Checkpoint Inhibitors in Ovarian Cancer through Cell Cycle Regulation

    by Shiqi Wang, Chenggui Luo, Jiaqing Guo, Rui Hu, Binglin Shen, Fangrui Lin, Chenshuang Zhang, Changrui Liao, Jun He, Yiping Wang, et al.

    Tumor cells invade normal surrounding tissues through continuous division. In this study, we hypothesized that cell cycle regulation changes the immune efficacy of ovarian cancer. To investigate this hypothesis, a Förster resonance energy transfer (FRET) sensor was constructed to characterize the cell activity in real time. Cell shrinkage caused by apoptosis induces the aggregation of proteins on the cell membrane, leading to variations in the fluorescence lifetime of FRET sensors. Moreover, we tracked cell activity across various cycles following co-culture with an immune checkpoint inhibitor. Consequently, we assessed how cell cycle regulation influences immunotherapy in a tumor mouse model. This approach, which involves inhibiting typical cell cycle processes, markedly enhances the effectiveness of immunotherapy. Our findings suggest that modulating the cycle progression of cancer cells may represent a promising approach to enhance the immune response of ovarian cancer cells and the efficacy of immunotherapy based on immune checkpoint inhibitors.


  • Open Access

    Removing non-resonant background of CARS signal with generative adversarial network

    by Ziyi Luo, Xiangcong Xu, Danying Lin, Junle Qu, Fangrui Lin, Jia Li

    Coherent anti-Stokes Raman scattering (CARS) microscopy requires the removal of non-resonant background (NRB) to ensure spectral accuracy and quality. This study introduces a deep-learning-based algorithm that leverages its enhanced capability for NRB removal and spectra retrieval. A generative adversarial network is trained using simulated noisy CARS data, enabling straightforward analysis of real CARS spectra obtained from pork belly and living mice brains. The results highlight the algorithm's ability to accurately extract vibrational information in the CH region. Importantly, this method eliminates the need for additional experimental measurements or extensive data preprocessing or postprocessing.